BioIntelliSense, Inc. — SEC Form D Filing
BioIntelliSense, Inc. filed an SEC Form D on December 19, 2025, reporting $58.05M raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- December 19, 2025
- Amount reported
- $58.05M
- Round stage
- Series B+
- Industry
- Health Technology
- Website
- https://www.biointellisense.com/
What the company does
Securities: Equity, Offering of Preferred Stock and the underlying shares of Common Stock issuable upon conversion of Preferred Stock.. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Hospitals and healthcare providers struggle with efficiently and continuously monitoring patients, both in-facility and at home, leading to delayed detection of deterioration and increased operational burdens.
Solution
BioIntelliSense provides a wearable device that continuously monitors vital signs and biometrics, coupled with a dashboard for analysis, to proactively identify patient decline and improve outcomes.
Why now
The increasing demand for remote patient monitoring, value-based care models, and the need for operational efficiency in healthcare due to staffing shortages and rising costs drive the adoption of continuous monitoring solutions.
Source: SEC EDGAR Form D filing